Develops the Science Eye, a retinal implant to restore vision, and other neurotechnology platforms led by former Neuralink president.

Vision & Sensory Prosthetics · Series C $230M

Vision & Sensory Prosthetics

Series C

$230M

HQ

Offers EEG-based brain-sensing headbands for education, focus training, prosthetic control, and wellness applications.

Non-Invasive Consumer EEG · Series B+ $286M

Non-Invasive Consumer EEG

Series B+

$286M

HQ

OpenAI-backed research lab building non-invasive, high-bandwidth brain-computer interfaces that read and write to neurons using molecules and ultrasound instead of implanted electrodes.

Non-Invasive Neuroimaging · Seed $250M

Non-Invasive Neuroimaging

Seed

$250M

HQ

Delivers a motor neuroprosthesis via the jugular vein into brain blood vessels, avoiding open brain surgery.

Endovascular BCI · Series D $200M

Endovascular BCI

Series D

$200M

HQ

Develops the Evoke closed-loop spinal cord stimulation system, the first SCS device that senses the spinal cord's ECAP response and adjusts therapy on every pulse.

Spinal & Peripheral Interfaces · IPO $150M

Spinal & Peripheral Interfaces

IPO

$150M

HQ

Develops soft, flexible neural electrode arrays designed to minimize scarring and improve long-term biocompatibility in brain implants.

Next-Gen Electrodes & Materials · Series A $55M

Next-Gen Electrodes & Materials

Series A

$55M

HQ

Embeds EEG sensors into everyday headphones to track focus, attention, and cognitive state for productivity and wellness.

Non-Invasive Consumer EEG · Series A $35M

Non-Invasive Consumer EEG

Series A

$35M

HQ

Develops in-ear EEG biosensors for continuous brain activity monitoring in wearable form-factors.

Non-Invasive Consumer EEG · Series A $16M

Non-Invasive Consumer EEG

Series A

$16M

HQ

Designs miniaturized, wireless neural implants with on-board AI processing to decode brain signals locally and reduce data bandwidth requirements.

Invasive Cortical Implants · Seed $10M

Invasive Cortical Implants

Seed

$10M

HQ

Develops high-bandwidth implantable brain-machine interfaces with thousands of electrode channels for paralysis and neurological conditions.

Invasive Cortical Implants · Series E $650M

Invasive Cortical Implants

Series E

$650M

HQ

Develops a flexible, thin-film electrode array placed on the brain surface to enable high-resolution neural recording with minimally-invasive placement.

Invasive Cortical Implants · Series C $102M

Invasive Cortical Implants

Series C

$102M

HQ

Provides virtual-reality and brain-sensing platforms for stroke rehabilitation and neurological recovery, combining VR with EEG-based neurofeedback.

Non-Invasive Clinical EEG · Growth $125M

Non-Invasive Clinical EEG

Growth

$125M

HQ

Engineers graphene-based neural interfaces for high-resolution, biocompatible brain recording and stimulation.

Next-Gen Electrodes & Materials · Series B $50M

Next-Gen Electrodes & Materials

Series B

$50M

HQ

Manufactures the Utah Array and other electrode systems used in academic BCI research and clinical trials for over a decade.

Invasive Cortical Implants · Strategic Investment $200M

Invasive Cortical Implants

Strategic Investment

$200M

HQ

Develops spinal cord stimulation platforms to restore movement and function in patients with spinal cord injury.

Spinal & Peripheral Interfaces · IPO $89.6M

Spinal & Peripheral Interfaces

IPO

$89.6M

HQ

Offers a rapid-deployment EEG system with AI-powered seizure detection for emergency and ICU settings.

Non-Invasive Clinical EEG · Market cap $671.2M

Non-Invasive Clinical EEG

Market cap

$671.2M

HQ

Develops minimally-invasive implanted muscle-machine (neuromuscular) interfaces for prosthetic and robotic control.

Develops magnetoelectric neural stimulation technology for non-invasive, deep-brain modulation targeting psychiatric and neurological disorders.

Neuromodulation & Stimulation · Series A $18.8M

Neuromodulation & Stimulation

Series A

$18.8M

HQ

Forest Neurotech is developing an ultrasound-based brain-computer interface for whole-brain imaging and neuromodulation, aiming to read from and stimulate deep brain structures less invasively than electrode implants.

Next-Gen Electrodes & Materials · Series A $14M

Next-Gen Electrodes & Materials

Series A

$14M

HQ

Builds a wearable headband that uses real-time EEG and acoustic stimulation to accelerate sleep onset and improve sleep quality.

Non-Invasive Consumer EEG · Seed $12M

Non-Invasive Consumer EEG

Seed

$12M

HQ

Produces wearable time-domain functional near-infrared spectroscopy headsets for brain activity measurement in research and commercial settings.

Non-Invasive Neuroimaging · Series C $53M

Non-Invasive Neuroimaging

Series C

$53M

HQ

Builds very-high-density cortical implants targeting tens of thousands of electrodes for speech and communication restoration.

Invasive Cortical Implants · Series A $33M

Invasive Cortical Implants

Series A

$33M

HQ

Builds the Crown, a wearable EEG headset with real-time brain-computer interface software for focus, meditation, and app control.

Non-Invasive Consumer EEG · Series A $5.0M

Non-Invasive Consumer EEG

Series A

$5.0M

HQ

MIT Media Lab spinout building the MouthPad^, a custom-fit intraoral touchpad that lets people control phones and computers hands-free with tongue and head gestures.

Assistive BCI Devices · Seed $4M

Assistive BCI Devices

Seed

$4M

HQ

Develops non-invasive transcranial electrical stimulation and EEG systems for research and clinical applications in epilepsy and neurorehabilitation.

Neuromodulation & Stimulation · Series A $17.5M

Neuromodulation & Stimulation

Series A

$17.5M

HQ

Produces augmented-reality headsets with integrated EEG for non-verbal communication and assistive technology for patients with speech and motor impairments.

Assistive BCI Devices · Seed $1.8M

Assistive BCI Devices

Seed

$1.8M

HQ

Provides AI-powered software that interprets brain and body signals from wearable sensors for emotional and cognitive state detection.

Non-Invasive Consumer EEG · Series A $10M

Non-Invasive Consumer EEG

Series A

$10M

HQ

Produces a transcranial direct current stimulation headset for at-home treatment of depression, combined with behavioral therapy.

Neuromodulation & Stimulation · Series A $9.3M

Neuromodulation & Stimulation

Series A

$9.3M

HQ

Develops the RNS System, a responsive neurostimulation device that detects and treats epileptic seizures in real time.

Neuromodulation & Stimulation · Market cap $439.5M

Neuromodulation & Stimulation

Market cap

$439.5M

HQ

Manufactures wireless EEG headsets and software for research, education, and consumer brain-computer interface applications.

Non-Invasive Consumer EEG · Seed $3.9M

Non-Invasive Consumer EEG

Seed

$3.9M

HQ

Provides open-source EEG, EMG, and ECG biosensing hardware and software for researchers and developers building BCI applications.

Non-Invasive Consumer EEG · Seed $1.8M

Non-Invasive Consumer EEG

Seed

$1.8M

HQ

Develops smart glasses with integrated EEG sensors for cognitive state monitoring and accessibility applications.

Non-Invasive Consumer EEG · Seed

Non-Invasive Consumer EEG

Seed

—

HQ

Reads and modulates the vagus nerve to treat chronic inflammatory diseases using implantable neural interfaces.

Spinal & Peripheral Interfaces · Series A

Spinal & Peripheral Interfaces

Series A

—

HQ

Joint venture between GSK and Verily developing bioelectronic medicines that modulate peripheral nerves for chronic disease treatment.

Spinal & Peripheral Interfaces · Series A

Spinal & Peripheral Interfaces

Series A

—

HQ

Manufactures research-grade neural recording systems and microelectrode arrays for preclinical and clinical BCI applications.

Invasive Cortical Implants

Invasive Cortical Implants

—

—

HQ

Research organization developing NeuroLife, a BCI system that bypasses spinal cord injury to restore hand and arm movement via cortical recording and muscle stimulation.

Invasive Cortical Implants

Invasive Cortical Implants

—

—

HQ

Manufactures clinical-grade EEG and BCI systems for research, rehabilitation, and assistive technology applications.

Non-Invasive Clinical EEG

Non-Invasive Clinical EEG

—

—

HQ

Provides spinal cord stimulation and deep brain stimulation devices for chronic pain, Parkinson's disease, and essential tremor.

Neuromodulation & Stimulation · Market cap $69.5B

Neuromodulation & Stimulation

Market cap

$69.5B

HQ

Manufactures deep brain stimulation, spinal cord stimulation, and other implantable neuromodulation devices for Parkinson's, pain, and movement disorders.

Neuromodulation & Stimulation · Market cap $109.3B

Neuromodulation & Stimulation

Market cap

$109.3B

HQ

Offers spinal cord stimulation, dorsal root ganglion stimulation, and deep brain stimulation systems for chronic pain and movement disorders.

Neuromodulation & Stimulation · Market cap $182.9B

Neuromodulation & Stimulation

Market cap

$182.9B

HQ